Clinical Trials Browser

Observational × envafolimab × Gastrointestinal × Clear all

NCT06643208 2025-06-26

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Gastrointestinal

Cholangiocarcinoma

NCT05645094 2022-12-13

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Not yet recruiting

GastrointestinalOther solid neoplasm

Locally Advanced Rectal Carcinoma